ONeil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, et al
Limited Human Trials While animal and preliminary in vitro research is promising, there are few well-controlled human clinical trials on BPC-157, and more data is needed to confirm safety, efficacy, and dosing parameters
Probiotics and prebiotics for the amelioration of type 1 diabetes: present and future perspectives
For more information on this drug class, please visit the ADAs Standards of Medical Care in Diabetes 2020 (source 7)
- Gamma-GlutamylTransferase (GGT)